Drug firm Glenmark Pharmaceuticals today said it has suspended clinical trial at the Malpani Hospital in Jaipur as soon as it became aware of the alleged irregularities at the hospital.
The company has "received the show-cause notice pertaining to the monitoring of the clinical trial at Malpani Hospital...," Glenmark Pharmaceuticals said in a BSE filing.
Coming out with a clarification on the news reports regarding clinical trial, the company said," As soon as the company became aware of the alleged irregularities at Malpani Hospital, the trials at the site were immediately suspended in the interest of patient safety."
Disclaimer: No Business Standard Journalist was involved in creation of this content